BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Alexander Nowak does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 CVRXCVRx Inc | Buy | $22.00 | Jan 2025 | −80.6% | Miss |
| CVRXCVRx Inc | Buy | $20.00 | Nov 2024 | −35.1% | Miss |
 BVSBioventus Inc | Buy | $17.00 | Sep 2024 | −34.4% | Miss |
 QDELQuidel Corporation | Buy | $57.00 | Sep 2024 | −25.1% | Miss |
| BVSBioventus Inc | Buy | $12.00 | Aug 2024 | +3.3% | Hit |
| CVRXCVRx Inc | Buy | $15.00 | Jul 2024 | −22.5% | Hit |
 CELCCelcuity LLC | Buy | $27.00 | May 2024 | −29.1% | Miss |
| CVRXCVRx Inc | Buy | $23.00 | May 2024 | −12.9% | Miss |
 DMACDiaMedica Therapeutics Inc | Buy | $8.00 | Apr 2024 | +65.0% | Miss |
 NTRANatera Inc | Buy | $117.00 | Apr 2024 | +41.3% | Hit |
| DMACDiaMedica Therapeutics Inc | Buy | $8.00 | Mar 2024 | +79.1% | Miss |
| BVSBioventus Inc | Buy | $9.00 | Mar 2024 | +85.0% | Hit |
 DRIODarioHealth Corp | Buy | $8.00 | May 2023 | −64.3% | Miss |
| DMACDiaMedica Therapeutics Inc | Buy | $12.00 | Jul 2022 | +190.8% | Miss |
| QDELQuidel Corporation | Buy | $219.00 | Jun 2021 | −9.5% | Miss |
| QDELQuidel Corporation | Buy | $341.00 | Mar 2021 | −41.3% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.